MedTrace Logo

Study of NanoDOX Hydrogel vs Placebo for Dehisced Surgical Wounds

NCT01547325 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-03-13

No results posted yet for this study

Summary

The purpose of this study is to determine the effects of NanoDOX Hydrogel versus Placebo Hydrogel on Dehisced Surgical Wounds.

Conditions

  • Dehisced Surgical Wounds

Interventions

DRUG

NanoDOX 1% doxycycline monohydrate Hydrogel

1% doxycycline monohydrate hydrogel

DRUG

placebo hydrogel

placebo hydrogel

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • NanoSHIFT LLC

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01547325 on ClinicalTrials.gov